SEBIA CAPI 3 IMMUNOTYPING

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Available from:

Sebia Singapore Pte Ltd

Class:

Class B IVD

Manufactured by:

SEBIA

Therapeutic area:

Clinical chemistry

Therapeutic indications:

The CAPI 3 IMMUNOTYPING kit is designed for the detection and the characterization of monoclonal proteins (immunotyping) in human urine and serum with the CAPILLARYS 3 instrument, SEBIA, for capillary electrophoresis. It is used in conjunction with the CAPI 3 PROTEIN(E) 6 kit, SEBIA, designed for proteins separation into 6 major fractions in alkaline buffer (pH 9.9). The CAPILLARYS 3 instrument performs all procedural sequences automatically to obtain a protein profile for qualitative analysis. Each urine or serum sample is mixed with individual antisera that are specific against gamma (Ig G), alpha (Ig A) and mu (Ig M) heavy chains, and kappa (free and bound) light chains and lambda (free and bound) light chains, respectively. The proteins, separated in silica capillaries, are directly detected by their absorbance at 200 nm. The electrophoregrams are evaluated visually to detect the presence of specific reactions with the suspect monoclonal proteins. For In Vitro Diagnostic Use.

Product summary:

Device System Info:-; Models: CAPILLARYS 3 OCTA - 1245, CAPI 3 IMMUNOTYPING - 2600, IT/IF CONTROL - 4788, CAPILLARYS 3 TERA - 1246

Authorization date:

2020-12-09